[Analysis of alveolitis (pneumonitis) as a complication of cytostatic (CMF) therapy].
作者信息
Tallósy I, Vargha G, Pölöskey A, Nagy Z, Kricskovits A
出版信息
Orv Hetil. 1987 Aug 2;128(31):1621-2.
PMID:3614922
Abstract
摘要
相似文献
1
[Analysis of alveolitis (pneumonitis) as a complication of cytostatic (CMF) therapy].[作为细胞抑制（CMF）疗法并发症的肺泡炎（肺炎）分析]
Orv Hetil. 1987 Aug 2;128(31):1621-2.
2
Case 6-1985: progressive pneumonitis after chemotherapy for breast cancer.病例6 - 1985：乳腺癌化疗后进行性肺炎
N Engl J Med. 1985 Jul 4;313(1):49-50. doi: 10.1056/NEJM198507043130115.
3
5
Randomized trial comparing cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) with rotational CMF, epirubicin and vincristine as primary chemotherapy in operable breast carcinoma.一项随机试验，比较环磷酰胺、甲氨蝶呤和5-氟尿嘧啶（CMF）与交替使用CMF、表柔比星和长春新碱作为可手术乳腺癌的一线化疗方案。
Cancer. 2002 Jul 15;95(2):228-35. doi: 10.1002/cncr.10678.
7
Adjuvant cyclophosphamide, methotrexate, and fluorouracil in premonopausal patients with node-positive breast cancer: indirect comparison of dose and schedule in DBCG trials 77, 82, and 89.绝经前淋巴结阳性乳腺癌患者辅助性环磷酰胺、甲氨蝶呤和氟尿嘧啶治疗：丹麦乳腺癌协作组（DBCG）77、82和89号试验中剂量与方案的间接比较
Acta Oncol. 2008;47(4):662-71. doi: 10.1080/02841860801989761.
8
[Sequential combination chemotherapy in metastatic cancer of the breast].[转移性乳腺癌的序贯联合化疗]
Medicina (B Aires). 1984;44(1):15-22.
9
Oral uracil and tegafur compared with classic cyclophosphamide, methotrexate, fluorouracil as postoperative chemotherapy in patients with node-negative, high-risk breast cancer: National Surgical Adjuvant Study for Breast Cancer 01 Trial.口服尿嘧啶和替加氟与经典的环磷酰胺、甲氨蝶呤、氟尿嘧啶相比，用于淋巴结阴性、高危乳腺癌患者术后化疗：国家乳腺癌辅助治疗研究01试验
J Clin Oncol. 2009 Mar 20;27(9):1368-74. doi: 10.1200/JCO.2008.18.3939. Epub 2009 Feb 9.
10
[Treatment of advanced breast cancer with 2 successive chemotherapeutic schedules].[采用两种连续化疗方案治疗晚期乳腺癌]
Medicina (B Aires). 1982;42(6 Pt 1):587-95.
Zotero 插件